Synthesis, antimicrobial activity and admet profiling of 2 substituted thiazolo[3,2-b][1,2,4]triazol-7-ium hexabromotellurates
Abstract
The thiazolo[3,2-b][1,2,4]triazol-7-ium hexabromotellurate derivatives 1–3 were synthesized via electrophilic heterocyclization of methallyl thioether precursors using an in situ generated Te(IV) reagent (TeO₂/HBr in CH₃CN) (Fig. 1). This one-step transformation simultaneously constructs the fused heterocyclic core and forms the biologically active TeBr₆²⁻ counterion, ensuring good atom economy and synthetic efficiency.